MeSH Browser

MeSH Heading: Nafronyl
Tree Number(s): D03.383.312.620
Unique ID: D009257
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D009257
Scope Note: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Entry Term(s): Artocoron; Azunaftil; Di-Actane; Dusodril; Gévatran; LS-121; Nafronyl Oxalate; Nafronyloxalate; Nafti Von Ct; Nafti-Puren; Nafti-Ratiopharm; Naftidrofuryl; Naftifurin Oxalate; Naftilong; Naftilux; Praxilene; Praxilène
Pharm Action: Serotonin Antagonists
Vasodilator Agents
Related Numbers: 31329-57-4; 5ADB8D9388
CAS Type 1 Name: 2-Furanpropanoic acid, tetrahydro-alpha-(1-naphthalenylmethyl)-, 2-(diethylamino)ethyl ester
Previous Indexing: Diethylamines (1974); Furans (1971-1974); Naphthalenes (1971-1974); Propionates (1971-1974)
Public MeSH Note: 91; was see under FURANS 1975-90
History Note: 91(75); was see under FURANS 1975-90
Date Established: 1991/01/01
Date of Entry: 1974/11/19
Revision Date: 2017/05/24

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Nafronyl MeSH Descriptor Data 2024